Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November…
Clinical
OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the…
Commercial
BioSpace Movers & Shakers, Oct. 30
Commercial
Q32 Stays Busy with $60 Million Series B and First Dose…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide…
Commercial
Oyster Point Pharma to Report Third Quarter 2020 Financial Results on…
Clinical
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Trevena, Inc. Announces DEA Scheduling of OLINVYK (oliceridine) injection – FirstWord…
Home
Commercial
Lawsuits/Bankruptcy
Lawsuits/Bankruptcy
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Lawsuits/Bankruptcy
Kezar Life Sciences Announces Orphan Drug Designations for KZR-616 for the Treatment of Polymyositis and Dermatomyositis
Biospace News
-
October 23, 2020
Lawsuits/Bankruptcy
Frequency Therapeutics Announces $42 Million Private Placement – FirstWord Pharma
Lawsuits/Bankruptcy
Tonix Pharmaceuticals Holding Corp. Closes $10.5 Million Common Stock Registered Direct Offering Nasdaq:TNXP
Lawsuits/Bankruptcy
Aquestive Therapeutics to Announce Second Quarter Financial Results and Recent Business Highlights on Aug 4 and Host Conference Call on Aug 5 at 8:00...
Lawsuits/Bankruptcy
FDA Approves Expanded BOTOX (onabotulinumtoxinA) Label for the Treatment of Pediatric Patients with Spasticity – FirstWord Pharma
Lawsuits/Bankruptcy
Ipsen Announces Updated Indication for Dysport (abobotulinumtoxinA) for the Treatment of...
Firstwordpharma News
-
July 12, 2020
0
Lawsuits/Bankruptcy
AbCellera Files Patent Infringement Lawsuit Against Berkeley Lights, Inc. – FirstWord...
Firstwordpharma News
-
July 12, 2020
0
Lawsuits/Bankruptcy
Rite Aid Announces Early Results and Increase in the Maximum Amount...
Biospace News
-
July 10, 2020
0
Lawsuits/Bankruptcy
Tonix Pharmaceuticals Completes Enrollment in Phase 3 RELIEF Trial of TNX-102...
Globenewswire News
-
July 10, 2020
0
Lawsuits/Bankruptcy
Tonix Pharmaceuticals Completes Enrollment in Phase 3 RELIEF Trial of TNX-102...
Biospace News
-
July 10, 2020
0
1
2
3
...
19
Page 1 of 19
- Advertisement -
MOST POPULAR
Blueprint Medicines Announces Accelerated Regulatory Submission Plans and Recent Clinical Progress
March 27, 2019
Biomunex Pharmaceuticals signs a licensing agreement with Sanofi for the development...
January 15, 2019
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
July 18, 2020
Lipella Pharmaceuticals Received FDA IND Approval for Phase-2a Oncology Supportive Care...
March 26, 2019
Load more
HOT NEWS
Others
MMS Holdings Doubles Growth in South Africa Region Amid Burgeoning Pharmaceutical...
Commercial
Infections Are Common in Patients Receiving Immune Checkpoint Inhibitors: Presented at...
Deals
Confo Therapeutics and DyNAbind announce drug discovery collaboration to identify novel...
Commercial
CASI Pharmaceuticals Announces The Appointment Of Wei-Wu He, Ph.D., Executive Chairman,...
